Mertigo SR sustained-release tablets

Dexa Medica

Ingredients in every sustained-release tablet

Betahistine 12 mg

Each package contains

10 strips of 10 sustained-release tablets

Other details

Dosage form:Tablet; coated; sustained-release
Flavour None

W.H.O. classification

ATC Level 1 N - Nervous system
ATC Level 2 N07 - Other Nervous System Drugs in ATC
ATC Level 3 N07C - Antivertigo Preparations

Warnings

Pregnancy

CAUTIONThis item may not be safe for use during pregnancy. Use with caution and after consultation with your doctor.

Lactation

CONSULT YOUR DOCTORSafety of this item for use during lactation has not been established. Please consult your doctor.

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

SAFE IF PRESCRIBEDThis item is safe for use while operating heavy machinery.

Available in

Indonesia

Dosage information

18 YEARS OLD AND ABOVE
1 sustained-release tablet (12 mg of betahistine mesylate) twice daily, taken orally after each meal. Betahistine mesylate sustained-release tablet must be swallowed whole and never crushed or chewed.

Indication

To relieve vertigo, dizziness which related to vestibular disorder in blood circulation disorder or Meniere’s syndrome, Meniere’s disease, and peripheral vertigo.

Back to products

Email

contact@dexagroup.com

Phone

+62 21 7454-111

Share this website

Address

Titan Center, 3rd Floor,
Jalan Boulevard Bintaro,
Block B7/B1 No. 5,
Bintaro Jaya,
Sector 7,
Tangerang 15224,
Indonesia

Dexagroup, Titan Center

Terms and Conditions

By accessing and using this website, you agree to the terms and conditions that have been set forth by us. Please read our full Terms and Conditions, including our Privacy Policy, for details. We comply with the General Data Protection Regulation (GDPR) of the European Union. 

Pharmacovigilance

It is crucial for patients and healthcare practitioners to report any adverse reactions to any medical product. This helps improve public health and safety, and enables researchers and manufacturers to accurately evaluate the benefit / risk balance of our medical products.

In case you experience any suspected adverse reaction or unexpected side-effect as a result of our medication, please reach us at +62 21 7454-111 (during working hours) or pv@dexagroup.com. For emergency assistance, please contact your healthcare practitioner immediately.

Accuracy

Considerable effort has been made to ensure that the information provided on this website is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive, and may become out-of-date or inaccurate without warning. Information is intended only to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service. The provided information is a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Medication

The absence of a warning for a given drug or drug combination should in no way be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Dexagroup or any related person or entity does not assume any responsibility for any aspect of healthcare administered with the aid of information on this website. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, or if you need medical assistance, please check with your doctor, nurse or pharmacist immediately.